Last reviewed · How we verify
Mulberry Twig Alkaloid Tablet
At a glance
| Generic name | Mulberry Twig Alkaloid Tablet |
|---|---|
| Also known as | Based on the original hypoglycemic treatment |
| Sponsor | Nanjing First Hospital, Nanjing Medical University |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- the Safety, Tolerability and Pharmacokinetics of Mulberry Twig Alkaloids in Human (PHASE1)
- Comparing the Efficacy of Mulberry Twig Alkaloid Tablet and Canagliflozin in Patients With Type 2 Diabetes (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: